In 2023, the mortality rate for malignant neoplasms of the colon, rectum, and anus in the UK was 26.5 deaths per 100,000 persons. Forecasted data indicates a stable trend from 2024 to 2027, maintaining at 26.5, with a slight increase to 26.6 in 2028. The lack of year-on-year variation suggests minimal change in mortality rates for these years. The compound annual growth rate (CAGR) also reflects stability, remaining nearly unchanged over the 2024 to 2028 period.
Future trends to watch for include potential impacts from advancements in medical technology, cancer treatment effectiveness, increased screening programs, and lifestyle changes. These factors may contribute to shifts in mortality rates, either maintaining the plateau or leading to declines in the future.